{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:11:03Z","timestamp":1778944263028,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018548","name":"Curtin University, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018548","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.rcsop.2026.100728","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:27:17Z","timestamp":1772731637000},"page":"100728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Physicochemical compatibility and stability of ketamine co-administered with selected supportive care drugs and parenteral nutrition in pediatric oncology"],"prefix":"10.1016","volume":"22","author":[{"given":"Katriina","family":"Varonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnathan","family":"Soggee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Czarniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2026.100728_bb0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmjspcare-2018-001739","article-title":"Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study","volume":"12","author":"Courade","year":"2019","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.rcsop.2026.100728_bb0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/1049909114543640","article-title":"Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics","volume":"32","author":"Taylor","year":"2015","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100728_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-015-0515-4","article-title":"Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study","volume":"15","author":"Sheehy","year":"2015","journal-title":"BMC Pediatr"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100728_bb0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1213\/01.ANE.0000118109.12855.07","article-title":"Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review","volume":"99","author":"Subramaniam","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.rcsop.2026.100728_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29693","article-title":"Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients","volume":"69","author":"Anghelescu","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rcsop.2026.100728_bb0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jpain.2007.02.429","article-title":"Ketamine as an adjuvant for treatment of cancer pain in children and adolescents","volume":"8","author":"Finkel","year":"2007","journal-title":"J Pain"},{"key":"10.1016\/j.rcsop.2026.100728_bb0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.paed.2020.03.008","article-title":"Intravenous access in children","volume":"30","author":"Bennett","year":"2020","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.rcsop.2026.100728_bb0040","first-page":"330","article-title":"Intravenous drug incompatibilities in the intensive careunit- a review","volume":"13","author":"Ramesan","year":"2021","journal-title":"J Pharm Sci Res"},{"key":"10.1016\/j.rcsop.2026.100728_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5935\/0103-507X.20160029","article-title":"Drug incompatibilities in the adult intensive care unit of a university hospital","volume":"28","author":"Marsilio","year":"2016","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.rcsop.2026.100728_bb0050","series-title":"General Chapters: Pharmaceutical Compounding - Sterile Preparations","author":"United States Pharmacopeia 2021","year":"2021"},{"key":"10.1016\/j.rcsop.2026.100728_bb0055","series-title":"Handbook on injectable drugs","author":"Trissel","year":"2009"},{"key":"10.1016\/j.rcsop.2026.100728_bb0060","author":"Pelletier"},{"key":"10.1016\/j.rcsop.2026.100728_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4212\/cjhp.v62i2.439","article-title":"Stability of hydromorphone-ketamine solutions in glass bottles, plastic syringes, and IV bags for pediatric use","volume":"62","author":"Ensom","year":"2009","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.rcsop.2026.100728_bb0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/jac\/dks510","article-title":"Stability and compatibility of vancomycin for administration by continuous infusion","volume":"68","author":"Raverdy","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rcsop.2026.100728_bb0075","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","article-title":"I. Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination","author":"Buxton","year":"2006"},{"key":"10.1016\/j.rcsop.2026.100728_bb0080","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.2147\/DDDT.S123411","article-title":"Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use","volume":"10","author":"Fang","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.rcsop.2026.100728_bb0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4212\/cjhp.v62i1.114","article-title":"Physical compatibility and chemical stability of ketamine-morphine mixtures in polypropylene syringes","volume":"62","author":"Donnelly","year":"2009","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.rcsop.2026.100728_bb0090","series-title":"Drug stability testing essentials 21.04.2025 ed","author":"ICH Guidelines","year":"2025"},{"key":"10.1016\/j.rcsop.2026.100728_bb0095","series-title":"Agilent OpenLab CDS (Version 3.4.0). [Chromatography Data System Software]. Santa Clara, CA, USA","year":"2024"},{"key":"10.1016\/j.rcsop.2026.100728_bb0100","series-title":"General Chapters: Globule Size Distribution in Lipid Injectable Emulsions","author":"United States Pharmacopeia 2021","year":"2021"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100728_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040466","article-title":"AmBisome\u00ae formulations for pediatrics: stability, cytotoxicity, and cost-effectiveness studies","volume":"16","author":"Zuccari","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.rcsop.2026.100728_bb0110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ajhp\/zxab066","article-title":"Stability of 10-mg\/mL and 50-mg\/mL ketamine oral solutions","volume":"78","author":"Ancedy","year":"2021","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100728_bb0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/10903127.2021.1934203","article-title":"Ketamine stability over six months of exposure to moderate and high temperature environments","volume":"26","author":"Foertsch","year":"2022","journal-title":"Prehosp Emerg Care"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100728_bb0120","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1213\/ANE.0000000000006956","article-title":"II. Physicochemical stability of ketamine after reconstitution for injection: a scoping review","volume":"138","author":"Usman","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1016\/j.rcsop.2026.100728_bb0125","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/ajhp\/zxaa299","article-title":"Compatibility of medications with intravenous lipid emulsions: effects of simulated Y-site mixing","volume":"77","author":"Ross","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.rcsop.2026.100728_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/15360288.2023.2284976","article-title":"The use of ketamine for malignant and non-malignant chronic pain in children. A review of current evidence","volume":"38","author":"AlGhamdi","year":"2024","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.rcsop.2026.100728_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40272-016-0168-2","article-title":"Pediatric oncology: managing pain at end of life","volume":"18","author":"Snaman","year":"2016","journal-title":"Paediatr Drugs"},{"issue":"e5","key":"10.1016\/j.rcsop.2026.100728_bb0140","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1136\/bmjspcare-2018-001739","article-title":"Low dose ketamine adjuvant treatment for refractory pain I children, adosecents and young adults with cancer: a pilot study","volume":"12","author":"Courade","year":"2022","journal-title":"BMJ Support Palliat Care"},{"issue":"7","key":"10.1016\/j.rcsop.2026.100728_bb0145","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/j.1552-4604.1994.tb02031.x","article-title":"Issues and problems associated with drug delivery in pediatric patients","volume":"34","author":"Roberts","year":"1994","journal-title":"J Clin Pharmacol"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:40:20Z","timestamp":1778942420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276626000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"alternative-id":["S2667276626000260"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100728","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physicochemical compatibility and stability of ketamine co-administered with selected supportive care drugs and parenteral nutrition in pediatric oncology","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100728"}}